Stomach cancer surgery may get simpler: omentum preservation under study
NCT ID NCT05180864
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares two surgical approaches for stomach cancer: removing the entire omentum (a fatty layer in the abdomen) versus preserving it. The omentum helps fight infections and prevent bowel blockages. Researchers want to see if keeping it leads to fewer complications without affecting survival. About 654 adults with resectable stomach cancer will be randomly assigned to one of the two procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
gastrectomy (surgery to remove part or all of the stomach)
What this could lead to
If successful, this could show that preserving the omentum during stomach cancer surgery is just as effective as removing it, while reducing complications like infections and bowel blockages.
What could go wrong
This is a non-inferiority trial, meaning it aims to prove that preserving the omentum is not worse than removing it. However, it is still recruiting and results are not yet available, so there is no guarantee of benefit or safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, North Holland, 1081 HV, Netherlands
Contact
-
Antoni van Leeuwenhoek
NOT_YET_RECRUITINGAmsterdam, Netherlands
-
Azienda Ospedaliera Universitaria
NOT_YET_RECRUITINGSiena, Italy
-
Catharina Ziekenhuis
RECRUITINGEindhoven, Netherlands
-
Elisabeth Tweesteden ziekenhuis
NOT_YET_RECRUITINGTilburg, Netherlands
-
Erasmus Medisch Centrum
NOT_YET_RECRUITINGRotterdam, Netherlands
-
Gelre ziekenhuis
NOT_YET_RECRUITINGApeldoorn, Netherlands
-
Leids Universitair Medisch Centrum
NOT_YET_RECRUITINGLeiden, Netherlands
-
Medisch Centrum Leeuwarden
NOT_YET_RECRUITINGLeeuwarden, Netherlands
-
Oxford University Hospitals
NOT_YET_RECRUITINGOxford, United Kingdom
-
Rijnstate ziekenhuis
NOT_YET_RECRUITINGArnhem, Netherlands
-
Universitair Medisch Centrum Utrecht
NOT_YET_RECRUITINGUtrecht, Netherlands
-
Universitait Medisch Centrum Groningen
NOT_YET_RECRUITINGGroningen, Netherlands
-
University Medical Center of the Johannes Gutenberg University
NOT_YET_RECRUITINGMainz, Germany
-
Ziekenhuis Groep Twente
NOT_YET_RECRUITINGAlmelo, Netherlands
-
Zuyderland ziekenhuis
NOT_YET_RECRUITINGHeerlen, Netherlands